Updated Jul 16, 2026
Simmons Jeffrey N has filed 7 SEC Form 4 filings across 1 company in the last 90 days — buying. Lifetime open-market purchases: $100K.
Jeffrey N. Simmons is the President and CEO of Elanco Animal Health Inc, a company specializing in animal health products. He has been instrumental in leading the company since its spin-off from Eli Lilly in 2018 and has held various leadership roles within the organization.
| Role | Insider |
|---|---|
| Notability | 50/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-19 | ELAN | Elanco Animal Health Inc | P — Open-market purchase | 5.0K | $20.09 | $100K |
| 2026-03-05 | ELAN | Elanco Animal Health Inc | F — Tax withholding / forfeiture | 37.9K | $24.88 | $943K |
| 2026-03-04 | ELAN | Elanco Animal Health Inc | A — Grant or award | 119.3K | $0.00 | |
| 2026-03-04 | ELAN | Elanco Animal Health Inc | F — Tax withholding / forfeiture | 230.0K | $26.40 | $6.07M |
| 2026-03-04 | ELAN | Elanco Animal Health Inc | A — Grant or award | 397.0K | $0.00 |
Jeffrey N. Simmons is the President and CEO of Elanco Animal Health Inc, a company specializing in animal health products. He has been instrumental in leading the company since its spin-off from Eli Lilly in 2018 and has held various leadership roles within the organization.…
7 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 1 open-market purchases ($100K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Simmons Jeffrey N profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.